Tourmaline Bio (TRML)
NASDAQ:TRML
US Market

Tourmaline Bio (TRML) Balance Sheet

285 Followers

Tourmaline Bio Balance Sheet

Tourmaline Bio's total assets for Q1 2024 were $359.17M, an increase of 70.79% from the previous quarter. TRML total liabilities were $5.03M for the fiscal quarter, a -4.25% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 210.29M$ 193.72M$ 254.82M$ 152.78M$ 41.94M
Total Liabilities
$ 5.25M$ 13.66M$ 8.61M$ 4.77M$ 59.04M
Total Equity Gross Minority
$ 205.04M$ 180.06M$ 242.81M$ 148.00M$ -17.10M
Total Capitalization
$ 205.24M$ 182.03M$ 242.81M$ 148.00M$ -17.10M
Preferred Stock Equity
-----
Capital Lease Obligations
-----
Currency in USD

Tourmaline Bio Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis